SAO PAULO, Aug. 11, 2011 /PRNewswire/ -- Companhia de
Bebidas das Americas – Ambev [BOVESPA: AMBV4, AMBV3; and NYSE: ABV,
ABVc] announces today its results for the 2011 second quarter (Q2
2011). The following financial and operating information, unless
otherwise indicated, is presented in nominal Reais and
prepared in accordance with International Financial and Reporting
Standards (IFRS), and should be read in conjunction with our
quarterly financial information for the three and six months period
ended June 30, 2011 filed with the
CVM and submitted to the SEC.
This press release segregates the impact of organic changes
from those arising from changes in scope or currency
translation.
Scope changes represent the impact of acquisitions and
divestitures other than those eliminated from the base, the start
up or termination of activities or the transfer of activities
between segments, curtailment gains and losses and year over year
changes in accounting estimates and other assumptions that
management does not consider as part of the underlying performance
of the business. Unless stated, percentage changes in this press
release are both organic and normalized in nature. Whenever used in
this document, the term "normalized" refers to performance measures
(EBITDA, EBIT, Profit, EPS) before special items. Special items are
either income or expenses which do not occur regularly as part of
the normal activities of the Company. They are presented separately
because they are important for the understanding of the underlying
sustainable performance of the Company due to their size or nature.
Normalized measures are additional measures used by management and
should not replace the measures determined in accordance with IFRS
as indicators of the Company's performance. Comparisons, unless
otherwise stated, refer to the second quarter of 2010 (Q2 2010).
Values in this release may not add up due to rounding.
OPERATING AND FINANCIAL HIGHLIGHTS
Top line performance: Net sales grew 6.2% driven mainly
by price increases across our regions, with Net Revenue/hl growing
7.1% in the period. Organic volume decrease of 0.9% across the
regions except for HILA-ex.
Cost of Goods Sold (COGS) and Selling, General &
Administrative (SG&A) expenses: COGS/hl increased by 9.3%
mainly due to raw materials and packaging costs as well as lower
fixed cost dilution, which were partly offset in the quarter by
gains in currency hedges. SG&A (excl. depreciation &
amortization) increased by 1.6% mainly as a result of general
inflation and higher logistic costs partially offset by lower
provision for variable compensation and cost savings
initiatives.
EBITDA, Operating Cash generation and Profit: Our
Normalized EBITDA reached R$ 2,583.6
million in Q2 2011, an organic growth of 9.0%, while margin
continued to further expand (+110bps) reaching 44.5% in the period.
Cash generated from operations in Q2 was R$ 2,589.3 million, a 1.4% increase as compared
to same 2010 period. Our Normalized Profit was R$ 1,837.3 million (+20.4%), while our Normalized
Earnings per share (EPS) grew 20.1%.
Payout and Financial discipline: We announced in the
quarter a R$ 1.26 billion payment in
dividends and interest on own capital (IOC), paid on Aug 5th, totaling R$ 3.06
billion payout year to date.
|
|
Financial highlights – Ambev
consolidated
|
|
|
%
As
|
%
|
|
|
%
As
|
%
|
|
R$ million
|
2Q10
|
2Q11
|
Reported
|
Organic
|
YTD
10
|
YTD
11
|
Reported
|
Organic
|
|
Total volumes
|
36,896.0
|
36,181.7
|
-1.9%
|
-0.9%
|
77,822.6
|
76,978.3
|
-1.1%
|
-0.3%
|
|
Beer
|
26,783.1
|
26,093.1
|
-2.6%
|
-1.2%
|
56,182.4
|
55,569.1
|
-1.1%
|
-0.2%
|
|
CSD and NANC
|
10,112.9
|
10,088.6
|
-0.2%
|
0.1%
|
21,640.2
|
21,409.2
|
-1.1%
|
-0.8%
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
5,678.4
|
5,811.6
|
2.3%
|
6.2%
|
11,799.8
|
12,373.7
|
4.9%
|
8.5%
|
|
Gross profit
|
3,739.4
|
3,793.0
|
1.4%
|
5.2%
|
7,861.8
|
8,248.1
|
4.9%
|
8.4%
|
|
Gross margin
|
65.9%
|
65.3%
|
-60 bps
|
-70 bps
|
66.6%
|
66.7%
|
10 bps
|
-10 bps
|
|
EBITDA
|
2,408.4
|
2,578.9
|
7.1%
|
9.4%
|
5,182.3
|
5,676.8
|
9.5%
|
11.7%
|
|
EBITDA margin
|
42.4%
|
44.4%
|
200 bps
|
130 bps
|
43.9%
|
45.9%
|
200 bps
|
130 bps
|
|
Normalized EBITDA
|
2,422.9
|
2,583.6
|
6.6%
|
9.0%
|
5,229.4
|
5,682.1
|
8.7%
|
10.9%
|
|
Normalized EBITDA
margin
|
42.7%
|
44.5%
|
180 bps
|
110 bps
|
44.3%
|
45.9%
|
160 bps
|
100 bps
|
|
Profit - Ambev
holders
|
1,510.2
|
1,832.6
|
21.3%
|
|
3,160.4
|
3,921.2
|
24.1%
|
|
|
Normalized Profit - Ambev
holders
|
1,525.5
|
1,837.3
|
20.4%
|
|
3,242.1
|
3,926.5
|
21.1%
|
|
|
No. of share outstanding
(millions)
|
3,095.5
|
3,104.2
|
|
|
3,095.5
|
3,104.2
|
|
|
|
EPS (R$/shares)
|
0.49
|
0.59
|
21.0%
|
|
1.02
|
1.26
|
23.7%
|
|
|
Normalized EPS
|
0.49
|
0.59
|
20.1%
|
|
1.05
|
1.26
|
20.8%
|
|
|
Note: Earnings per share
calculation is based on outstanding shares (total existing shares
excluding shares held in treasury).
|
|
|
|
|
|
|
|
|
|
|
CONTACT: Tatiana S F Rodrigues, Ambev Investor Relations,
+ 55 (11) 2122-1414, ir@ambev.com.br
SOURCE Companhia de Bebidas das Americas - Ambev